Abstract:Mansoor M Aman, 1 Ammar Mahmoud, 2 Timothy Deer, 3 Dawood Sayed, 4 Jonathan M Hagedorn, 5 Shane E Brogan, 6 Vinita Singh, 7 Amitabh Gulati, 8 Natalie Strand, 9 Jacqueline Weisbein, 10 Johnathan H Goree, 11 Fangfang Xing, 12 Ali Valimahomed, 13 Daniel J Pak, 14 Antonios El Helou, 15 Priyanka Ghosh, 16 Krishna Shah, 17 Vishal Patel, 1 Alexander Escobar, 18 Keith Schmidt, 19 Jay Shah, 20 Vishal Varshney, 21 William Rosenberg, 22 Sanjeet Narang 23 1 Department of Anesthesiology, Division of Pain Medicine, Advocate Aurora Health, Oshkosh, WI, USA; 2 Department of Anesthesiology, Division of Pain Medicine, Northern Light Health Eastern Maine Medical Center, Bangor, ME, USA; 3 The Spine and Nerve Center of the Virginias, Charleston, WV, USA; 4 Department of Anesthesiology, Pain and Perioperative Medicine, University of Kansas Medical Center, Kansas City, KS, USA; 5 Department of Anesthesiology and Perioperative Medicine, Division of Pain Medicine, Mayo Clinic, Rochester, MN, USA; 6 Department of Anesthesiology, Division of Pain Medicine, University of Utah, Salt Lake City, UT, USA; 7 Department of Anesthesiology, Division of Pain Medicine, Emory University, Atlanta, GA, USA; 8 Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 9 Department of Anesthesiology, Division of Pain Medicine, Mayo Clinic, Phoenix, AZ, USA; 10 Department of Anesthesiology, Chronic Pain Division, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 11 Interventional Pain Medicine, Napa Valley Orthopedic Medical Group, Napa, CA, USA; 12 Swedish Pain Services, Swedish Health Services, Seattle, WA, USA; 13 Gramercy Pain Center, Holmdel, NJ, & Advanced Orthopedics Sports Medicine Institute, Freehold, NJ, USA; 14 Department of Anesthesiology, Division of Pain Medicine, New York-Presbyterian Hospital/Weill Cornell Medical College, New York, NY, USA; 15 Department of Neurosciences, Division of Neurosurgery, The Moncton Hospital, Moncton, NB. Assistant Professor, Department of Surgery, Dalhousie University, Halifax, NS, Canada; 16 Remedy Medical Group, San Francisco, CA, USA; 17 Assistant Professor of Anesthesiology, Baylor St. Luke's Medical Center, Baylor College of Medicine, Houston, TX, USA; 18 Department of Anesthesiology and Pain Medicine, University of Toledo Medical Center, Toledo, OH, USA; 19 AMITA Neurosciences Institute, Comprehensive Pain Management Program, St. Alexius Medical Center, Hoffman Estates, IL, USA; 20 SamWell Institute for Pain Management, Colonia, NJ, USA; 21 Department of Anesthesia, Providence Healthcare, Vancouver, BC, Canada & Department of Anesthesiology, Pharmacology, Therapeutics, University of British Columbia, Vancouver, BC, Canada; 22 Center for the Relief of Pain, Midwest Neurosurgery Associates, Kansas City, Missouri, USA; 23 Department of Anesthesiology, Pain and Perioperative Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Correspondence: Mansoor M Aman Interventional Pain Medicine, Department of Anesthesiology, Advocate Aurora Health, Oshkosh, WI, 54904, USA Tel +1 920-456-7715 Email Moderate to severe pain occurs in many cancer patients during their clinical course and may stem from the primary pathology, metastasis, or as treatment side effects. Uncontrolled pain using conservative medical therapy can often lead to patient distress, loss of productivity, shorter life expectancy, longer hospital stays, and increase in healthcare utilization. Various publications shed light on strategies for conservative medical management for cancer pain and a few international publications have reviewed limited interventional data. Our multi-institutional working group was assembled to review and highlight the body of evidence that exists for opioid utilization for cancer pain, adjunct medication such as ketamine and methadone and interventional therapies. We discuss neurolysis via injections, neuromodulation including targeted drug delivery and spinal cord stimulation, vertebral tumor ablation and augmentation, radiotherapy and surgical techniques. In the United States, there is a significant variance in the interventional treatment of cancer pain based on fellowship training. As a first of its kind, this best practices and interventional guideline will offer evidenced-based recommendations for reducing pain and suffering associated with malignancy. <str -Abstract Truncated-

ASPMN Position Statement: Authorized Agent Controlled Analgesia

Pain Assessment in the Patient Unable to Self- Report: Clinical Practice Recommendations in Support of the ASPMN 2024 Position Statement

Beyond pain intensity scores: Aligning ASPMN-endorsed practices with administration of PRN analgesia

Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.

The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain

Outpatient Patient Controlled Analgesia (PCA) for the Palliative Care Patient

Drivers of Patient Controlled Analgesia (PCA) Use in Children

[About safety parameters for patient-controlled analgesia (PCA) devices]

The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain

Patient-Controlled Analgesia (PCA): Intravenous Administration (IV-PCA) versus Oral Administration (Oral-PCA) by Using a Novel Device (PCoA® Acute) for Hospitalized Patients with Acute Postoperative Pain—A Comparative Retrospective Study

Impact of Patient-Controlled Analgesia (PCA) Smart Pump-Electronic Health Record (EHR) Interoperability with Auto-Documentation on Chart Completion in a Community Hospital Setting

Prescription Drug Prices

PCA-pump for analgesia following pediatric scoliosis surgery: bolus administration with/without basal infusion

The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain

AAAPT Diagnostic Criteria for Acute Neuropathic Pain

AAPM&R consensus guidance on spasticity assessment and management

Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study

The Impact of Prior Authorization on Clinical Practice and Patient Care Outcomes: A Work Group Report of the AAAAI Prior Authorization Task Force

DEA-registered clinical pharmacist practitioners: Progressing practice to increase patient care access

A Randomized Comparison of Multimodal Analgesia and Fentanyl-Based Patient-Controlled Analgesia in Women Undergoing Robot-Assisted Bilateral Axillary Breast Approach Thyroidectomy

Safety and Efficacy of Axon Therapy (SEAT Study), Utilizing Magnetic Peripheral Nerve Stimulation (mPNS) for Treatment of Neuropathic Pain